Voyager Therapeutics stock soars on Pfizer deal By: Boston Business Journal via Business Journals October 06, 2021 at 11:24 AM EDT Shares of Cambridge biotech Voyager Therapeutics Inc. are up more than 60% on the news that the company inked a $630 million licensing deal with Pfizer Inc. Read More >>
